Literature DB >> 7191758

Arrhythmia in hypertrophic cardiomyopathy.

.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7191758      PMCID： PMC1714428          DOI： 10.1136/bmj.281.6247.1026

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Prognosis and mortality of hypertrophic obstructive cardiomyopathy.

Authors:  T Hardarson; C S De la Calzada; R Curiel; J F Goodwin
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

2.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Authors:  D R Rosing; K M Kent; B J Maron; S E Epstein
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

3.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Authors:  M Kaltenbach; R Hopf; G Kober; W D Bussmann; M Keller; Y Petersen
Journal:  Br Heart J       Date:  1979-07

4.  Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy.

Authors:  J F Goodwin; D M Krikler
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

5.  Rhythm disturbances in hypertrophic cardiomyopathy: prevalence, relation to symptoms and management.

Authors:  M I Canedo; M J Frank; A M Abdulla
Journal:  Am J Cardiol       Date:  1980-04       Impact factor: 2.778

6.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  D D Savage; S F Seides; B J Maron; D J Myers; S E Epstein
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.

Authors:  W J McKenna; S Chetty; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

8.  Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.

Authors:  B J Maron; W C Roberts; J E Edwards; H A McAllister; D D Foley; S E Epstein
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.